Credit Suisse Ag Eli Lilly & CO Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Eli Lilly & CO stock. As of the latest transaction made, Credit Suisse Ag holds 1,584,543 shares of LLY stock, worth $1.18 Billion. This represents 1.22% of its overall portfolio holdings.

Number of Shares

1,584,543

Previous 1,516,345 4.5%

Holding current value

$1.18 Billion

Previous $884 Million 39.46%

% of portfolio

1.22%

Previous 0.87%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $40.4 Million - $54 Million	68,198 Added 4.5%	1,584,543 $1.23 Billion
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $68.3 Million - $80.5 Million	-130,089 Reduced 7.9%	1,516,345 $884 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $6.57 Million - $9.05 Million	15,107 Added 0.93%	1,646,434 $884 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $15.7 Million - $20.9 Million	-44,663 Reduced 2.66%	1,631,327 $765 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $15.8 Million - $18.5 Million	50,717 Added 3.12%	1,675,990 $576 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $33.9 Million - $39.5 Million	105,337 Added 6.93%	1,625,273 $595 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $9.3 Million - $10.6 Million	31,367 Added 2.11%	1,519,936 $491 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $4.79 Million - $5.63 Million	17,201 Added 1.17%	1,488,569 $483 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $10.4 Million - $13 Million	44,471 Added 3.12%	1,471,368 $421 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $21 Million - $26 Million	-93,240 Reduced 6.13%	1,426,897 $394 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $20.8 Million - $25.6 Million	93,845 Added 6.58%	1,520,137 $351 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $4.11 Million - $5.32 Million	22,769 Added 1.62%	1,426,292 $327 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $28.8 Million - $37.3 Million	175,323 Added 14.27%	1,403,523 $262 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $7.31 Million - $9.68 Million	-56,059 Reduced 4.37%	1,228,200 $207 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $17.6 Million - $20.4 Million	-120,389 Reduced 8.57%	1,284,259 $190 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $32.6 Million - $39.2 Million	-239,055 Reduced 14.54%	1,404,648 $231 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $150 Million - $186 Million	-1,261,139 Reduced 43.42%	1,643,703 $228 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $66.8 Million - $82.7 Million	624,475 Added 27.38%	2,904,842 $382 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $11.7 Million - $12.7 Million	-109,407 Reduced 4.58%	2,280,367 $255 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $5.07 Million - $5.92 Million	-45,791 Reduced 1.88%	2,389,774 $265 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $107 Million - $126 Million	964,587 Added 65.57%	2,435,565 $316 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $36.5 Million - $40.9 Million	-344,507 Reduced 18.98%	1,470,978 $170 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $33.9 Million - $42.3 Million	394,617 Added 27.77%	1,815,485 $195 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $8.02 Million - $9.21 Million	-105,955 Reduced 6.94%	1,420,868 $121 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $6.16 Million - $7.27 Million	-82,997 Reduced 5.16%	1,526,823 $118 Million
Q4 2017 Mar 14, 2018	BUY	$81.94 - $87.89 $168,796 - $181,053	2,060 Added 0.13%	1,609,820 $136 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $4.93 Million - $5.28 Million	-60,131 Reduced 3.61%	1,607,760 $136 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $2.51 Million - $2.79 Million	-32,606 Reduced 1.92%	1,667,891 $143 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,700,497	1,700,497 $140 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account